Press release
Premature Ejacu*lation Treatment Global Market Size ($5.62 Billion Revenue By 2028) Growing Rapidly with Recent Trends and Outlook
Premature Ejacu*lation Treatment Market
As per the report, the premature Ejacu*lation treatment market size has grown strongly in recent years. It will grow from $3.53 billion in 2023 to $3.88 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The premature Ejacu*lation treatment market size is expected to see strong growth in the next few years. It will grow to $5.62 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13518&type=smp
Rising Prevalence Of Sexual Disorders Fuels Growth In The Premature Ejacu*lation Treatment Market
The increasing prevalence of sexual disorders is expected to propel the growth of the premature Ejacu*lation treatment market going forward. Sexual disorder or dysfunction refers to the difficulty faced by both men and women during any phase of regular intimate activity. Premature Ejacu*lation is a sexual disorder where premature Ejacu*lation treatment involving medications or therapeutic approaches addresses and controls this condition. For instance, in November 2021, according to a survey of 2,000 UK adults conducted by Pharmacy Direct GB, a UK-based online pharmacy, around 48% of UK residents reported experiencing erectile dysfunction, representing about 16.5 million individuals. The National Health Service spent over $17,9 million (£13 million) for Erectile Dysfunction treatment prescriptions in 2021. Further, in July 2022, according to a survey of 1,000 men across the UK by Click2Pharmacy, a UK-based provider of local prescription treatment services, around 58.2% experienced erectile dysfunction in the UK and 3 in 4 men between the ages of 25 and 34 experience erectile dysfunction in 2022. Therefore, the increasing prevalence of sexual disorders is driving the growth of the premature Ejacu*lation treatment market.
Innovative Delay Sprays Transforming The Premature Ejacu*lation Treatment Market
Major companies operating in the premature Ejacu*lation treatment market are developing new solutions, such as delay sprays, to drive revenues in the market. Delay sprays, specifically prepared products applied to the pen*is before sexual activity to assist men last longer during sexual intercourse, work by momentarily dulling pen*is nerves, lowering pen*is sensitivity, and postponing Ejacu*lation. For instance, in August 2023, Maude, a US-based sexual wellness company, launched Stay, a delay spray explicitly designed to address premature Ejacu*lation. This product is infused with 10% lidocaine, a fast-evaporating local anesthetic that reduces sensitivity in the male genital region. Furthermore, Stay is compatible with both latex and polyisoprene condoms, as well as various lubricants and devices. It's vegan-friendly, fragrance-free, and free from sulfates, silicones, and parabens.
The premature Ejacu*lation treatment market covered in this report is segmented -
1) By Type: Antidepressants (SSRIs), Phosphodiesterase-5 Inhibitors, Topical Anesthetics, Analgesics, Other Treatment
2) By Route of Administration: Oral, Topical
3) By Distribution Channel: Retail, Direct-To-Consumer
4) By Application: Hospital, Retail Pharmacy, Online Pharmacy, Other Applications
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13518&type=discount
Major companies operating in the premature Ejacu*lation treatment market report are Pfizer Inc., Johnson & Johnson, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Menarini Group, Lupin Limited., Amneal Pharmaceuticals Inc., Mankind Pharma Ltd., Cipla Limited, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd., ANI Pharmaceuticals Inc., Sagent Pharmaceuticals Inc., Vivus Inc., Absorption Pharmaceuticals LLC, Innovus Pharmaceuticals Inc., Sunrise Pharmaceuticals Inc., Solco Healthcare US LLC, Apricus Biosciences Inc., Regent Pacific Group Limited, Endurance RP Ltd.
Contents of the report:
1. Executive Summary
2. Premature Ejacu*lation Treatment Market Report Structure
3. Premature Ejacu*lation Treatment Market Trends And Strategies
4. Premature Ejacu*lation Treatment Market - Macro Economic Scenario
5. Premature Ejacu*lation Treatment Market Size And Growth
…..
27. Premature Ejacu*lation Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/premature-Ejacu*lation-treatment-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Premature Ejacu*lation Treatment Global Market Size ($5.62 Billion Revenue By 2028) Growing Rapidly with Recent Trends and Outlook here
News-ID: 3574331 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Ejacu*lation
Premature Ejacu*lation Treatment Global Market Size, Top Companies, Share Report …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Premature ejacu*lation Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $5.62 billion In…
Anesthesia Depth Monitoring Device Market Size 2024 to 2031.
Market Overview and Report Coverage
Anesthesia depth monitoring devices are used to measure the depth of anesthesia during surgical procedures to ensure patient safety and optimize anesthesia levels. These devices help healthcare providers to monitor and adjust anesthesia to prevent over-sedation or under-sedation based on the patient's individual needs.
The future outlook for the anesthesia depth monitoring device market is promising, with a projected growth at a CAGR of 7.30%…
Biochem introduces GMO-free ReaShure® Precision Release Choline in Germany, and …
Biochem, a trusted manufacturer of high-quality animal feed additives, has recently started offering GMO-free ReaShure® in Germany, and the Baltic region. This rumen-protected Choline is critical to ruminant health and has been a part of Biochem’s prod-uct portfolio for the last five years.
Biochem is pleased to announce that the Precision Release Choline formu-lation ReaShure® is now available as a GMO-free product in Germany, and the Baltic region. Cur-rently operating in…
New SGS Lab in Vietnam for Jewelry and Candle Making Sectors
In January 2017, SGS officially opened a new laboratory at Hai Phong, in northern Vietnam. The current focus of the facility is on providing state-of-the-art compliance testing facilities and services to the jewelry and candle making industries.
With major centers of jewelry and candle manufacture nearby, the laboratory offers a full range of physical and chemical testing services for both industries. During 2017, the facility aims to start issuing reports independently,…
G+H receives first European approval for an electrical installation duct
Ludwigshafen (Germany), 3 August, 2015 – On 04.06.2015, the Centre of Competence for Construction granted G+H ISOLIERUNG the first European approval (ETA-15/0293) for the PYROMENT-IK 90® Type BD electrical installation duct. The installation duct manufactured by G+H is therefore the first product of its type that can be sold and fitted throughout Europe.
Its fire resistant properties were checked in accordance with the European test standard EN 1366-5. To pass…
Announcement Pursuant to Art. 4 para. 2 of Commission Regulation (EC) No. 2273/2 …
The Management Board of XING AG has resolved with the consent of the Supervisory Board to buy back shares of the company with a value of up to EUR 4 million. The share buyback shall be conducted from November 11, 2008 on and is to be ended on April 30, 2009 at the latest.
With this move, the Management Board makes use of the authorization to acquire own shares accounting for…
